Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Clinical trial NCT01525225 · TERMINATED
Trial details
- NCT number
- NCT01525225
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.